Target intelligence / Profile preview

Olfactomedin-like protein 1 (OLFML1)

Target
OLFML1
Molecular classification
Other (Secreted, extracellular matrix glycoprotein; member of the olfactomedin domain-containing protein family)
01

Overview

Olfactomedin-like protein 1 (OLFML1) is a secreted glycoprotein of the olfactomedin family, encoded by the OLFML1 gene located on human chromosome 11p15.4[1][4]. It contains an olfactomedin domain and consists of 402 amino acids[1][4]. OLFML1 is highly expressed in non-neural tissues such as small intestine, liver, lung, heart, and spleen, and has minimal to no expression in the brain[1][4]. Its protein enhances human cancer cell proliferation *in vitro* through acceleration of the cell cycle S phase entry[1], and it is involved in osteoblast biology—specifically, it inhibits Hippo signaling and affects mineralization, thus contributing to bone development and potentially to diseases like congenital scoliosis via effects on osteoblast differentiation[3]. Although OLFML1 belongs to a protein family implicated in several pathological processes, its explicit physiological and pathological roles, as well as its therapeutic targeting potential, require further research[1][3][4].

Other names
Olfactomedin-like 1OLFML1ONT2UNQ564/PRO1126UNQ564MVAL564
02

Biological functions

Cell proliferationRegulation of osteoblast mineralization (via inhibition of Hippo signaling)Extracellular matrix organization (inferred from family and secretion)
03

Disease associations

Cancer (promotes cancer cell proliferation)Skeletal disease (implicated in congenital scoliosis, abnormal bone development via Hippo/YAP pathway)

Beyond the preview

Go deeper on Olfactomedin-like protein 1 (OLFML1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Olfactomedin-like protein 1 (OLFML1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call